| Description | JPI 547, also known as NOV 1402, is an oral inhibitor of PARP 1/2 and Tankyrase 1/2. JPI-547 demonstrated anti-tumor activity in BRCA-deficient xenograft models as a single-agent and in combination with chemotherapy and immune checkpoint inhibitors. |
| molecular weight | 473.402 |
| Molecular formula | C23H26Cl2N6O |
| CAS | 2055357-65-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |